Article
FGF2 antagonizes aberrant TGFβ regulation of tropomyosin: role for posterior capsule opacity.
Journal of cellular and molecular medicine - 1 May 2017
Kubo Eri, Shibata Shinsuke, Shibata Teppei, Kiyokawa Etsuko, Sasaki Hiroshi, Singh Dhirendra P
Abstract excerpt
Transforming growth factor (TGF) β2 and fibroblast growth factor (FGF) 2 are involved in regulation of posterior capsule opacification (PCO) and other processes of epithelial-mesenchymal transition (EMT) such as cancer progression, wound healing and tissue fibrosis as well as normal embryonic development. We previously used an in vivo rodent PCO model to show the expression of tropomyosin (Tpm) 1/2 was aberrantly...
Topics
- Actins
- Animals
- Biomarkers
- Capsule Opacification
- Cell Movement
- Cell Shape
- Epithelial Cells
- Epithelial-Mesenchymal Transition
- Fibroblast Growth Factor 2
- Humans
- Lens Capsule, Crystalline
